Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Augmentin Intravenous 1.2g powder for solution for injection vials (GlaxoSmithKline UK Ltd) |
| BNF code | 0501013K0BBAHAF |
| Virtual Medicinal Product | Co-amoxiclav 1000mg/200mg powder for solution for injection vials |
| Name | Augmentin Intravenous 1.2g powder for solution for injection vials |
| Abbreviated name | Augmentin Intravenous 1.2g inj vials |
| Date of name applicability | 18 May 2004 |
| Previous name | Augmentin Intravenous 1.2g injection vials |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | Not available |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.